Chad Orevillo
Pearl Therapeutics
2
0
2
N/A
0
1
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (2)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Ke-Yun Chao, PhD
Fu Jen Catholic University
Shared therapeutic areas:
Nikolaos Harokopos, MD
General hospital of Pyrgos, Peloponnese, Greece
Shared therapeutic areas:
Konrad E Bloch, MD
University Hospital, Zürich
Shared therapeutic areas:
Anastasios Palamidas, MD
Sotiria Pulmonary Hospital of Athens
Shared therapeutic areas:
loic MONDOLONI
Assistance Publique Hopitaux De Marseille
Shared therapeutic areas:
Anna Gavriilidou, MD
Papageorgiou hospital of Thessaloniki, Greece
Shared therapeutic areas:
Areti Xifteri-Nikolinati, MD
Messini, Greece
Shared therapeutic areas:
Maria Katertzi, MD
Private office, Moudania, Thessaloniki, Greece
Shared therapeutic areas:
Talant M Sooronbaev, MD
National Center of Cardiology and Internal Medicine, Bishkek, Kyrgyzstan
Shared therapeutic areas:
Evangelia Tsikrika, MD
General hospital of Veroia, Greece
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (2)
Showing 2 of 2 trials
A Study to Assess the Effects of PT001 and PT005 MDI on Specific Image Based Parameters in Subjects With Moderate to Severe COPD
A Study to Assess the Effects of PT003 and Placebo MDI on Specific Image Based Airway Volumes and Resistance in Subjects With Moderate to Severe COPD
All 2 trials loaded